Clinical Trial Update: A Study of Monthly Risedronate for Osteoporosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating monthly risedronate for postmenopausal osteoporosis has completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: Warner Chilcott | Conditions: Postmenopausal Osteoporosis | Phase 3 | Status: COMPLETED | Results posted: 2011-06-21